Bishwanath Chatterjee

机构：National Cancer Institute, Center for Cancer Research · ORCID：0000-0003-2390-2966

发表论文 104 篇 · 总被引 2588 次 · h-index 26

代表论文

Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis (2022 · European Journal of Endocrinology · 被引 6)
Fusion transcription factor dosage controls cell state in rhabdomyosarcoma (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma (2025 · Molecular Cancer Therapeutics · 被引 1)
Supplementary Table 2 from Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma (2026)
Supplementary Table 1 from Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma (2026)
Supplementary Figure 1 from Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma (2026)